Ma, Y., Chen, X., Wang, M., Meng, J., Zhu, D., Chen, L., Xiao, Y., Yi, D., Shi, H., Liu, H., Cheng, X., Su, Y., Ye, J., Chi, H., Zhou, Z., Liu, T., Yang, C., Teng, J., Sun, Y., Jia, J., Hu, Q. (2025). Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome. Blood. https://doi.org/10.1182/blood.2024024362